Recent ZURA News
- Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024 • Business Wire • 06/14/2024 10:00:00 AM
- Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology • Business Wire • 06/06/2024 10:00:00 AM
- Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024 • Business Wire • 06/03/2024 10:00:00 AM
- Zura Bio Announces Participation in June Investor Conferences • Business Wire • 05/29/2024 10:00:00 AM
- Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights • Business Wire • 05/09/2024 10:00:00 AM
- Zura Bio Announces Oversubscribed $112.5 Million Private Placement • Business Wire • 04/18/2024 01:22:00 PM
- Zura Bio Announces Robert Lisicki as CEO and Director • Business Wire • 04/08/2024 10:00:00 AM
- Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer • Business Wire • 03/28/2024 10:00:00 AM
- Zura Bio Announces Participation at March Conferences • Business Wire • 03/04/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:30:45 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:02:53 PM
- Zura Bio Announces Participation at February Investor Conferences • Business Wire • 02/02/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:32:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:30:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:27:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:25:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 11:03:32 AM
- Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO • Business Wire • 01/08/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 11:04:01 AM
- Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit • Business Wire • 01/03/2024 11:00:00 AM
- Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok • Business Wire • 12/04/2023 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 10:53:10 PM
- Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors • Business Wire • 11/14/2023 11:00:00 AM
- Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights • Business Wire • 11/13/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 08:30:24 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM